Cochlear statement on US tariff announcement
Filed with ASX · · 1 page · English
Summary by 6ix AI
Cochlear Limited has issued a statement regarding a recent US tariff announcement affecting exports from Australia. The company confirms it can still utilize a provision for duty-free importation of certain products, including hearing implants, into the US. Cochlear will continue to monitor the global landscape to ensure it can provide hearing solutions to its customers.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cochlear
- Cochlear awaits clarification on application of US tariff
- Cochlear Named Most Trustworthy Healthcare Company in the World
- Cochlear North America Celebrates International Cochlear Implant Day by Announcing 2025 Academic Scholarship Winners
- HY25 Result - ASX & Media Release
- HY25 Result - Presentation Slides
Later from Cochlear
- Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
- Cochlear provides update to FY25 earnings guidance
- Cochlear Launches World's First and Only Smart Cochlear Implant System
- Appendix 4E
- FY25 Result - Presentation
Follow Cochlear into a list and get an email when it puts out news.
Follow Cochlear